Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002518329 | SCV000286362 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002378979 | SCV002670991 | likely benign | Cardiovascular phenotype | 2018-11-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003338478 | SCV004048914 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 2 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV005003574 | SCV005628429 | uncertain significance | not provided | 2024-07-17 | criteria provided, single submitter | clinical testing | In silico analysis supports a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |